Sort
48,018 grants matching “immunotherapy”
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
$383,865Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
Regulation of Lymphocyte Development by HLH Proteins
$383,864Barbara Lynne Kee · University Of Chicago · R01 · FY2014 · AI
Investigating Correlates and Therapeutics of Fatigue in Cancer Patients
$383,837Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2014 · NR
Inducing NK cells to remember and fight cancer
$383,822Jeffrey S Miller · University Of Minnesota · R01 · FY2016 · HL
Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$383,814Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2016 · AI
Biased chemokine receptor signaling in cancer progression
$383,766Michael B Dwinell · Medical College Of Wisconsin · R01 · FY2023 · CA
Role of iNKT Cells in Autoimmunity and Atherosclerosis
$383,750Amy S Major · Vanderbilt University · R01 · FY2011 · HL
Modifying T Cell Responses by Combinatorial Targeting of Negative regulators
$383,750Nevil John Singh · University Of Maryland Baltimore · R56 · FY2014 · AI
Modulation of chronic vascular inflammation by iNKT cells
$383,750Luc Van Kaer · Vanderbilt University · R01 · FY2009 · HL
Mechanisms and consequences of iNKT cell anergy
$383,750Luc Van Kaer · Vanderbilt University · R01 · FY2007 · AI
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$383,750Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2021 · CA
Modulation of chronic vascular inflammation by iNKT cells
$383,750Luc Van Kaer · Vanderbilt University · R01 · FY2010 · HL
Modulation of chronic vascular inflammation by iNKT cells
$383,750Luc Van Kaer · Vanderbilt University · R01 · FY2011 · HL
Role of iNKT Cells in Autoimmunity and Atherosclerosis
$383,750Amy S Major · Vanderbilt University · R01 · FY2010 · HL
Role of iNKT Cells in Autoimmunity and Atherosclerosis
$383,750Amy S Major · Vanderbilt University · R01 · FY2009 · HL
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$383,750Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2020 · CA
Priming pancreatic ductal adenocarcinoma using blood thinners to sensitize the efficacy of checkpoint immunotherapy
$383,750Taslim A Al-Hilal · University Of Texas El Paso · SC1 · FY2023 · GM
Role of sub-activation-threshold TCR interactions in maintaining T cell memory
$383,750Nevil John Singh · University Of Maryland Baltimore · R01 · FY2019 · AI
Role of iNKT Cells in Autoimmunity and Atherosclerosis
$383,750Amy S Major · Vanderbilt University · R01 · FY2008 · HL
OCULAR IMMUNOPATHOLOGY IN AUTOIMMUNE MODELS
$383,748Johns Hopkins University · R01 · FY2001 · EY
Harnessing microRNAs within miR-17-92 cluster for autoimmune intervention
$383,736Qijing Li · Duke University · R56 · FY2011 · AI
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
$383,713Robert David Schreiber · Washington University · R01 · FY2018 · CA
Adenovirus as a Vector for Gene Therapy
$383,698Patrick Hearing · State University New York Stony Brook · R01 · FY2007 · AI
Role of sub-activation-threshold TCR interactions in maintaining T cell memory
$383,692Nevil John Singh · University Of Maryland Baltimore · R01 · FY2015 · AI
Strategies to Enhance Adoptive Transfer T Cell Clones
$383,603Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA